Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.19 NOK | -0.45% | +3.30% | -16.41% |
Mar. 14 | Hofseth BioCare ASA Announces Board Changes | CI |
Feb. 09 | Hofseth BioCare ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Sales 2022 | 120M 11.01M | Sales 2023 | 219M 19.98M | Capitalization | 1.04B 94.64M |
---|---|---|---|---|---|
Net income 2022 | -137M -12.53M | Net income 2023 | -107M -9.78M | EV / Sales 2022 | 11.4 x |
Net Debt 2022 | 71.74M 6.56M | Net Debt 2023 | 257M 23.49M | EV / Sales 2023 | 5.91 x |
P/E ratio 2022 |
-8.89
x | P/E ratio 2023 |
-9.7
x | Employees | 70 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 41.78% |
1 day | -0.45% | ||
1 week | +3.30% | ||
Current month | +5.29% | ||
1 month | -1.79% | ||
3 months | -14.12% | ||
6 months | -23.16% | ||
Current year | -16.41% |
Managers | Title | Age | Since |
---|---|---|---|
Jon Olav Ødegård
CEO | Chief Executive Officer | 51 | 13-02-28 |
Roger Hofseth
CEO | Chief Executive Officer | 50 | 99-12-31 |
Crawford Currie
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Roger Hofseth
CEO | Chief Executive Officer | 50 | 99-12-31 |
Director/Board Member | 53 | 15-04-30 | |
Director/Board Member | 49 | 15-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 2.19 | -0.45% | 893 |
24-04-22 | 2.2 | +2.33% | 3,196 |
24-04-19 | 2.15 | -2.27% | 2,551 |
24-04-18 | 2.2 | +4.76% | 155,683 |
24-04-17 | 2.1 | -0.94% | 230,409 |
Real-time Oslo Bors, April 23, 2024 at 10:45 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-16.41% | 78.78M | |
-3.33% | 270B | |
-3.38% | 93.37B | |
+2.99% | 46.38B | |
+1.57% | 40.95B | |
+9.06% | 40.18B | |
+0.95% | 38.05B | |
-6.02% | 28.43B | |
+15.38% | 23.11B | |
-10.01% | 22.86B |
- Stock Market
- Equities
- HBC Stock